Search
The WasteWatcherLooking at All the Wrong Places for Pay-Fors
Democrats are busy looking for ways to pay for their $3.5 trillion spending bill and you will be part of the calculation.
The WasteWatcherCotton is Rotten for the Environment
Plastic shopping bags have over the past several years have become an unnecessary pariah.
The WasteWatcherWill Michigan's State Legislators Micromanage PBMs?
Interfering in private contracts between pharmacy benefit managers and their customers will drive drug costs up, not down.
Op-EdsConsumers will feel pain if pharmacy benefit managers are over-regulated
Columbus Dispatch: Lowering drug costs should be achieved through marketplace reforms.
The WasteWatcherGood News Out of the Philippines on ENDS Products
How foreign grant money turned the tide of ENDS products in the Philippines.
The WasteWatcherClimate Change is Not New or the End of the World
Steve Koonin's WSJ OpEd “Climate Change Brings a Flood of Hyperpole" sends a sober message about the Green New Deal
Letters to OfficialsCCAGW Urges Senate to Oppose S. Amendment 3635
Adding more price controls would be destructive to U.S. pharmaceutical research and future costs.
The WasteWatcherWhat’s Worse than Most Favored Nation – Budget Reconciliation
The Biden administration proposes to recind President Trump's Most Favored Nation Policy.
The WasteWatcherCMS Provides the Proof – Sec. 1332 Waivers Have Lowered Health Insurance Premium Costs
A CMS report confirms a Trump administration initiative to lower healthcare costs worked spectacularly.
Letters to OfficialsCCAGW Joins Coalition Opposing Public Option in Healthcare
August 4, 2021 The Honorable Patty Murray Chair Committee on Health, Education, Labor, and Pensions U.S. Senate Washington, D.C. 20510
The WasteWatcherPublic Favors Government Drug Negotiations, Until They Learn What It Really Means
Senate Democrats are preparing to move a $3.5 trillion “human infrastructure” bill, but have to find ways to offset the cost.
Agency CommentsCAGW Submits Comment to FDA on IQOS 3 Modified Risk Tobacco Product Application
IQOS 3 is a tobacco harm reduction product and should receive a Modified Risk Tobacco Product designation quickly
